Condition
Citrate Transporter Deficiency
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Enrolling By Invitation2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06144957Enrolling By InvitationPrimary
SLC13A5 Deficiency Natural History Study - United States Only
NCT04681781Enrolling By InvitationPrimary
SLC13A5 Deficiency Natural History Study - Remote Only
NCT02500082UnknownPrimary
Triheptanoin (UX007) to Treat Citrate Transporter Deficiency
Showing all 3 trials